Honorary RSPH Associate Professor Tony Badrick is the CEO of the Royal College of Pathologists Australia Quality Assurance Program. He gave this talk on Thursday 25 March, and about a dozen people attended in person and on Zoom.
Tony also presented a variety of statistics and views of COVID-19, this time from the Australian perspective. His talk concentrated on the development of the assay for COVID-19, because of course that link in the chain did not exist before the virus began to spread.
From a pathology laboratory point of view, the most interesting outcome of the pandemic has been the changing perception of the work labs do. For instance, many people used to think that when you do a blood test in a lacks office down at the Mall or wherever, the sample was analysed right there behind the offices on site. Not so!
From a statistical point of view, Tony’s most interesting point was about the use of pooled samples to increase efficiency in the lab, because most of the samples are going to be negative in this country with such a successful response to the pandemic.